CIBC Bancorp USA’s Oruka Therapeutics ORKA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$419K Buy
5,026
+2,199
+78% +$207K ﹤0.01% 1474
2026
Q2
$269K Buy
+2,827
New +$188K ﹤0.01% 1602

Other funds holding ORKA

CIBC Bancorp USA's ORKA Position: Q3 2026 in Review

CIBC Bancorp USA increased its Oruka Therapeutics (ORKA) stake by 78% in Q3 2026, buying an estimated $207K and bringing the position to 5,026 shares worth $419K. The position accounts for ﹤0.01% of the portfolio, ranked #1474.

CIBC Bancorp USA first reported a position in ORKA in Q2 2026 and has held it in 2 quarters since. 212 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • CIBC Bancorp USA held 5,026 shares of Oruka Therapeutics worth $419K as of Q3 2026.
  • CIBC Bancorp USA bought 2,199 Oruka Therapeutics shares in Q3 2026, an estimated $207K.
  • Oruka Therapeutics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1474 holding.
  • CIBC Bancorp USA first reported a position in Oruka Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 212 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.